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Abstract
Background: Since 2005, malaria control scale-up has progressed in many African countries. Controlled studies of
insecticide-treated mosquito nets (ITNs), indoor residual spraying (IRS), intermittent preventive treatment during
pregnancy (IPTp) and malaria case management suggested that when incorporated into national programmes a
dramatic health impact, likely more than a 20% decrease in all-cause childhood mortality, was possible. To assess
the extent to which national malaria programmes are achieving impact the authors reviewed African country
programme data available through 2009.
Methods: National survey data, published literature, and organization or country reports produced during
2000-2009 were reviewed to assess available malaria financing, intervention delivery, household or target
population coverage, and reported health benefits including infection, illness, severe anaemia, and death.
Results: By the end of 2009, reports were available for ITN household ownership (n = 34) and IPTp use (n = 27) in
malaria-endemic countries in Africa, with at least two estimates (pre-2005 and post-2005 intervals). Information
linking IRS and case management coverage to impact were more limited. There was generally at least a three-fold
increase in household ITN ownership across these countries between pre-2005 (median of 2.4% of households with
at least one ITN) and post-2005 (median of 32.5% of households with at least one ITN). Ten countries had temporal
data to assess programme impact, and all reported progress on at least one impact indicator (typically on
mortality); in under-five year mortality rates most observed a decline of more than 20%. The causal relationship
between malaria programme scale-up and reduced child illness and mortality rates is supported by biologic
plausibility including mortality declines consistent with experience from intervention efficacy trials, consistency of
findings across multiple countries and different epidemiologic settings, and temporal congruity where morbidity
and mortality declines have been documented in the 18 to 36 months following intervention scale-up.
Conclusions: Several factors potentially have contributed to recent health improvement in African countries, but
there is substantial evidence that achieving high malaria control intervention coverage, especially with ITNs and
targeted IRS, has been the leading contributor to reduced child mortality. The documented impact provides the
evidence required to support a global commitment to the expansion and long-term investment in malaria control
to sustain and increase the health impact that malaria control is producing in Africa.
Background
The Roll Back Malaria (RBM) Partnership endorsed “Scale
Up for Impact” (SUFI) as the approach to rapidly increase
access to and use of malaria control interventions (as
referenced in its Global Malaria Action Plan [1]). SUFI is
predicated on the rapid deployment of a package of pro-
ven malaria interventions to high levels of coverage to
quickly achieve the optimal health effects based on evi-
dence from controlled trials (see Figure 1). Programme
impact accrues from multiple intervention effects and,
when scaled to high coverage nationwide, is expected to
have greater impact than any one intervention alone.
Experience in national programme scale-up has identi-
fied key determinants of achieving impact by assuring
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full package of proven malaria interventions. The pre-
ventive interventions–insecticide-treated nets (ITNs)
[2-5], indoor residual spraying (IRS) [6-9], and preven-
tion in pregnancy with intermittent preventive treatment
(IPTp) and ITNs [10-12]–all have documented efficacy
from controlled trials. Malaria case management is
clearly assumed to be effective as an intervention, but
cannot be tested in placebo-controlled trials because not
giving treatment to a malaria-infected person is unac-
ceptable; as a consequence, efficacy estimates for this
intervention are not based on clinical trials. Further, the
only data available are either summarized expert opinion
[13] or time-sequence data from health facilities to pro-
vide estimates of protective efficacy for case manage-
ment with mortality as the outcome [14-17]. These
efficacy estimates have been recently reviewed and cali-
brated for use in models that can estimate the expected
benefit in lives saved based on intervention coverage
achieved [18].
From 2005 through 2009, a number of countries have
scaled up programme coverage, particularly with pre-
vention interventions, to levels that have achieved mea-
sureable impact. Similarly, data were available from
large-scale, but sub-national, malaria control scale-up
efforts where impact was documented [19]. In analysing
the results of these national and large sub-national pro-
grammes, it is important to critically assess the causal
relationships across a range of national estimates and
programming contexts. This report summarizes recent
progress in sub-Saharan African countries and makes
the case for attributing health impact to the malaria
programme interventions.
Methods
Information was reviewed from national household
population-based surveys–including Demographic and
Health Surveys (DHS) [20], Multiple Indicator Cluster
Surveys (MICS) [21], Malaria Indicator Surveys (MIS)
[22], and AIDS Indicator Surveys (AIS) [23]–as well as
published literature and a variety of organization reports
examining changes from 2000 through 2009 (with
emphasis on the interval from 2004 through 2009) in
reported delivery of malaria prevention and control
products (ITNs, IRS, drugs for prevention and treat-
ment), changes in intervention coverage rates, and
reported health benefits (infection, illness, and death).
Because malaria is largely a disease of the rural poor
and because inequities in intervention delivery have his-
torically resulted in rural and poor populations being
underserved [24], the authors focused on estimates of
intervention coverage in rural areas of the countries as
reported in standard surveys. Standard outcome and
impact measures have been set through an iterative
review process managed by the RBM Monitoring and
Evaluation Reference Group (MERG) [25-27]. The core
health impact measures are: 1) all-cause mortality of
children younger than five years (in Africa and similar
high-endemic settings); 2) parasite prevalence within age
groups (0-59 months or 6-59 months); 3) anaemia
(Hb < 8.0 gm/dl) rates in young children (6-59 or 6-36
months of age); 4) outpatient case rates preferably with
laboratory confirmation; 5) in-patient admission rates
preferably with laboratory confirmation; and 6) case
fatality rates preferably with laboratory confirmation of
parasitaemia. Because rural populations are typically at
highest risk of malaria and have historically benefited
Figure 1 Malaria programme scale-up: relationship between coverage and expected burden reduction. Note: Programme scale-up
showing gradual incremental coverage increases (in red) versus rapid and accelerated coverage increases (in blue); the expected concomitant burden
reduction suggests that the rapid and accelerated approach leads to an increased burden reduction and added benefit (in gray) from accelerated
scale-up. This graphic assumes a direct relationship between population-based intervention coverage and programme impact; it also suggests a time
lag between achieving high coverage and having the population experience the intervention benefit (perhaps across a malaria transmission season).
Steketee and Campbell Malaria Journal 2010, 9:299
http://www.malariajournal.com/content/9/1/299
Page 2 of 15the least by disease control programme scale up, an ana-
lysis for rural areas is provided where it was available;
“rural” was defined by each country using their national
office of statistics’ definitions for population-based
surveys.
To assess the strength of the evidence for a causal link
between the scale-up of malaria control interventions
and reductions in child morbidity and mortality, consid-
ered established criteria for causal association were con-
sidered [28]. Several country experiences were reviewed
in detail for Tanzania [29-33] and Zanzibar [34], Zambia
[35-38], and Bioko Island (Equatorial Guinea) [39-41] to
further address aspects of causal association.
Results
Malaria prevention programme scale-up in Africa
Many countries across sub-Saharan Africa have rapidly
increased their malaria prevention coverage, particularly
with ITNs, but also with IRS in targeted areas and with
I P T pa n dI T N si np r e g n a n tw o m e n .F i g u r e2d e m o n -
strates the substantial progress since 2005 in scaling up
ITN programmes; it shows national estimates for rural
areas (where most of the malaria transmission occurs) in
ITN household ownership in 33 countries in sub-Saharan
Africa with 29 of these countries having at least two
national estimates during the pre-2005 and 2005 through
2009 time interval. Prior to 2005, most countries
recorded less than 5% of households having at least one
ITN (median of 2.4% ownership). While only three coun-
tries exceeded 60% of households with at least one ITN
in rural areas from 2005 through 2009, 10 exceeded 40%
and 17 exceeded 25% of rural households with at least
one ITN (median of 32.5% ownership for the post-2005
surveys). Figure 3 shows the progress in use of IPTp and/
or ITNs in pregnant women in 28 countries; while nine
countries have exceeded 25% use of IPTp or ITNs in
rural pregnant women, 19 have coverage levels below
20%. Figure 4 shows ITN ownership estimates across the
African continent by pre-2005 and 2005 through 2009
i n t e r v a l st op r o v i d eap r o f i l eo ft h eg e o g r a p h i cd i s t r i b u -
tion of the scale-up. In general, this increase in coverage
coincides with dramatic growth in external committed
financing for malaria control from approximately US
$100 million in 2003 to US$1.7 billion in 2009 [42]. The
scale-up timing lags by approximately one year after the
funding becomes available due to the time required for
commodity procurement and distribution.
Evidence for programme impact
Based both on country reports and those published in
peer-reviewed journals [19], there is consistent temporal
evidence for impact (e.g., morbidity and mortality reduc-
tion) as malaria programme coverage has increased
in countries in the Africa region. Information from
2000-2008 on malaria control progress was reviewed
from countries where data were available in the pub-
lished literature. Some countries and sub-national
regions (South Africa, Swaziland, southern Mozambique
and Eritrea; see references [57-63] and [45,46] respec-
tively) reported progress from 2000 through 2004. The
majority of countries (Benin, Burundi [43,44], Ethiopia
[47-50], Equitorial Guinea [39-41], Gambia [51,52],
Kenya [53-56], Rwanda [64], Senegal [67], United
Republic of Tanzania [29-34], and Zambia [35-38]) had
demonstrable progress from 2005 through 2009. Four
countries (Cameroon [68]; Congo [69]; Madagascar [70];
and Sudan [71]) had early reports of little or no progress
and three countries (Burkina Faso [72], Nigeria [73] and
Zimbabwe [74]) had early reports of worsening malaria;
more recent information on improved funding and
scale-up for malaria control has been reported from
these countries but is not yet adequately documented.
Countries and areas with published data on national
intervention scale-up and impact include: Equatorial Gui-
nea-Bioko Island, Eritrea, Ethiopia, Gambia, Kenya,
Rwanda, São Tomé and Príncipe, South Africa-Swaziland-
Mozambique in the Lubombo Spatial Development Initia-
tive (LSDI) Project, Tanzania (mainland and Zanzibar),
and Zambia. Figure 5 shows percentage point increases in
coverage for malaria prevention interventions during the
past decade for these 10 settings. Marked increases in IRS
coverage were documented in the LSDI area and on the
islands of Bioko, São Tomé and Príncipe, and Zanzibar;
most countries relied predominately on ITN scale-up with
some use of IRS and IPTp. Figure 6 shows the temporal
reduction in childhood morbidity and mortality.
Country vignette: Mainland Tanzania and Zanzibar
Malaria control scale-up has progressed on both main-
land Tanzania [29-33] and on Zanzibar [34]. Mainland
Tanzania with its large geographic area and population
has yet to achieve full scale-up across all districts, but
has increased household ownership of ITNs in both
urban and rural areas. In 1999, the Tanzania DHS
reported that while 20% of children under five years of
age reportedly slept under a mosquito net, only 10% of
these nets were treated with insecticide–thus there was
an estimated 2% use of ITNs in 1999. By the 2007-
2008 DHS, 39% (59% in urban and 33% in rural areas)
o fh o u s e so w n e da tl e a s to n eI T N ;a n dt h eu s eo fI P T p
in pregnant women had risen to 30% nationwide.
Between 2006 and 2008, malaria parasite prevalence in
children under five years of age declined by nearly 30%
from 20% to 14%; and in some areas with higher
household ITN ownership, the decline was more dra-
matic [33].
In contrast to the gradual improvement on mainland
Tanzania, rapid deployment and high coverage of IRS
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Page 3 of 15Figure 2 Percent coverage in rural areas of countries where households own at least one insecticide-treated net (ITN): pre-2005
coverage level (blue) and post-2005 increase in coverage levels (red) from national survey data. Source: Demographic and Health Surveys
(MACRO, http://www.measuredhs.com); Multiple Indicator Cluster Surveys (UNICEF, http://www.childinfo.org); and Malaria Indicator Surveys (RBM,
http://www.rollbackmalaria.org).
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Page 4 of 15and ITNs was achieved on Zanzibar, as has the use of
diagnostics and artemisinin-based combination therapy
(ACT). Zanzibar’s dramatic scale-up of IRS and of ACT
began in the 2003 through 2004 time interval and
increasing household ownership of ITNs occurred
between 2005 and 2006; increasing use of diagnostics
began in the 2006 through 2007 interval. This scale-up
coincided with documented reductions in child morbid-
ity and mortality; this includes a 68% reduction in out-
patient malaria diagnoses, a 75% reduction in malaria
Figure 3 Percent coverage in rural areas of the countries using prevention in pregnant women–either repeated use of intermittent
preventive treatment during pregnancy (IPTp) or ITN use. *These estimates were not specified as two or more doses of sulphadoxine-
pyrimethamine received at antenatal clinic visit. ~These estimates reflect pregnant women sleeping under an ITN the night before the survey; all
others are IPTp received among women giving birth in the past two years. Source: Demographic and Health Surveys (MACRO, http://www.
measuredhs.com), Multiple Indicator Cluster Surveys (UNICEF, http://www.childinfo.org), and Malaria Indicator Surveys (RBM, http://www.
rollbackmalaria.org).
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Page 5 of 15hospital admission, a 63% reduction in blood transfu-
sion, and a 72% reduction in overall malaria-attributed
mortality [34].
Country vignette: Zambia
From 2004 through 2008, Zambia increased household
ITN ownership and use and IPTp coverage nation-wide;
IRS was initially targeted to urban and peri-urban areas
of 12 districts, eventually expanding to 36 of the 72 dis-
tricts. ACT was initiated in 2004, but coverage of ACT
for clinical or confirmed malaria cases has not experi-
enced the same dramatic increase as that seen as a
result of scale-up of prevention intervention coverage.
Figure 7 shows this scale-up of coverage from 2001
through 2008: households owning at least one ITN (40%
increase), households owning two or more ITNs (64%
increase), households with IRS in the last 12 months
(58% increase), and children and pregnant women sleep-
ing under an ITN (80% and 85% increase, respectively).
The increased coverage rate of malaria prevention
interventions from 2001 through 2008 coincided with
reductions in child parasitaemia rates, which fell 53%,
with most of the decline in rural areas, and child anae-
mia rates, which fell 68%, (see Figure 8). All-cause child
mortality rates decreased between the DHS of 2001-02
and 2007 (reductions for 0-5 year age group, 1-11
month age group, and 1-4 year age group were 29%,
38%, and 36%, respectively). Specific analysis of the 2006
MIS data comparing households with ITNs versus
households without ITNs showed that after adjusting
for other known associations (including child age,
urban-rural status, socio-economic status, and use of
IRS), children living in houses with ITNs had significant
reductions in morbidity in the two year interval: 28%
fewer fever episodes in the previous two weeks, 39%
lower rates of P. falciparum infection, and 28% less
severe anaemia (Hb < 8 gm/dl). Households owning two
or more ITNs had the best results in morbidity reduc-
tion. Reported paediatric hospital admissions, hospital
deaths attributed to malaria (not all parasitologically
confirmed), and paediatric outpatient visits for suspected
malaria have similarly decreased, particularly in the 2006
through 2008 interval [37].
Potential contributing factors to the decline in all-cause
infant and child mortality were examined (Figure 9).
Most health indicators reflected no or only modest
improvement during the 2001 through 2008 interval;
there were no changes in immunization coverage rates or
treatment coverage rates for diarrheal or respiratory dis-
eases during this interval. DHS and MIS survey data
comparisons identified a nearly 50% reduction in the fre-
quency of underweight children (from 28% to 15%) and a
substantial increase in the rate of exclusive breastfeeding
in infants less than six months of age (from 15% to 35%)
from 2005 through 2007. While better breastfeeding
practices may have contributed to improved child sur-
vival, this alone would not be expected to account for
the observed large reductions in child mortality. The
Figure 4 Geographic distribution in Africa of household ownership of at least one insecticide-treated net (ITN) from national surveys
in the intervals of 1999-2004 and 2005-2009. Source: Demographic and Health Surveys (MACRO, http://www.measuredhs.com), Multiple Indicator
Cluster Surveys (UNICEF, http://www.childinfo.org), and Malaria Indicator Surveys (RBM, http://www.rollbackmalaria.org).
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of age may have been due to a variety of factors including
reduced malaria infections in the population (there were
no changes in stunting and wasting). The largest change
in intervention coverage that could have positively
impacted child survival during this time interval and at
this magnitude was the scale-up of malaria control
interventions.
Country vignette: Bioko Island, Equatorial Guinea
A substantial effort in Bioko Island started in 2004 with
rapid, large-scale increases in twice-yearly IRS coverage,
Figure 5 Percentage point increases in core malaria interventions in 10 countries reporting substantial improvement with malaria
intervention scale-up. Source: Demographic and Health Surveys (MACRO, http://www.measuredhs.com), Multiple Indicator Cluster Surveys (UNICEF,
http://www.childinfo.org), Malaria Indicator Surveys (RBM, http://www.rollbackmalaria.org), and country reports.
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Page 7 of 15introduction of diagnostics, ACT, and use of IPTp; this
was followed with ITN introduction in 2007. Figure 10
shows the immediate and steep reduction in all-cause
child mortality (a 69% reduction, from a pre-intervention
interval average of 152 to a post-intervention interval aver-
age of 55 per 1000 live births) associated with this malaria
control scale-up. There were concomitant reductions
in vector populations (over 90% reduced), mosquito
Figure 6 Percent changes in key malaria indicators in countries with substantial malaria control programme scale-up. Source: Impact of
national malaria control scale-up programs in Africa: magnitude and attribution of effects. Report for the Malaria Control and Evaluation Partnership
in Africa (MACEPA)/PATH, Seattle, USA citing the following articles: Zambia [38], Zanzibar [34], Rwanda and Ethiopia [48].
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Page 8 of 15sporozoite prevalence rates (over 90% reduced), parasite
prevalence rates in children under five years of age (68%
reduced), fever rates (89% reduced), and severe anaemia
rates (Hb <8 gm/dl; 87% reduced) [41].
Discussion
The past five years have witnessed the adoption of SUFI by
many malaria-endemic African countries, deploying effica-
cious interventions and collecting comparable indicators
Figure 7 Malaria intervention coverage rates from national surveys (2001-2008), and parasitaemia and anaemia rates from Malaria
Indicator Surveys (2006 and 2008) in Zambia. Note: National survey data is available for 2001-2002, 2004, 2006, 2007, and 2008; interim annual
estimates are linear extrapolations between known data points. HH: households; IPTp: intermittent preventive treatment in pregnancy; IRS: indoor
residual spraying; ITN: insecticide-treated net; anaemia = Hb <8 gm/dl.
Figure 8 Malaria intervention coverage rates per national surveys (2001-2008) and infant and child mortality rates (DHS 2001-2002
and 2007) in Zambia. Note: National survey data is available for 2001-2002, 2004, 2006, 2007, and 2008; interim annual estimates are linear
extrapolations between known data points. IPTp: intermittent preventive treatment in pregnancy; IRS: indoor residual spraying; ITN: insecticide-treated
net.
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malaria morbidity. There is remarkable consistency in
impact across a diverse range of countries. Among the set-
tings describing marked progress, three are islands (Bioko,
São Tomé and Príncipe, and Zanzibar with a combined
population of approximately 1.5 million), there is a three-
country partnership (LSDI working with some districts in
each of Mozambique, South Africa, and Swaziland); three
are small countries (Eritrea, Gambia, and Rwanda with a
combined population of approximately 16 million), and
three are larger countries (Ethiopia, Tanzania, and Zambia
with a combined population of more than 100 million).
The epidemiologic and demographic breadth of these set-
tings cannot yet be claimed to be representative of the
diversity of malaria in Africa. But additional countries are
progressing with malaria programme scale-up, and while
it is understood that there is an inherent interval between
programme scale-up and documenting programme out-
comes, it is clear that a broad and representative profile of
programme impact is emerging.
Figure 9 Changes in intervention coverage, malaria morbidity and mortality, and other child health intervention coverage in Zambia
between 2001 and 2008. Source: Demographic and Health Surveys (DHS) in 2001-2 and 2007; Malaria Indicator Surveys (MIS) in 2006 and 2008.
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improvement in child survival
With the increasing documentation of geographic
expansion of malaria programme scale-up in the Africa
region, it is important to assess whether the observed
health benefits are simply associations in time and place,
or if convincing evidence exists to assert a causal rela-
tionship between the malaria control interventions and
the dramatic documented health improvements.
Based on B.A. Hill’s 1965 epidemiologic framework for
causal inference [28], eight criteria need to be consid-
ered: 1) experimental evidence; 2) plausibility; 3)
strength of association; 4) specificity of the association;
5) temporal congruity [or lack of temporal ambiguity];
6) biologic gradient; 7) consistency of findings; and 8)
coherence of the evidence. For the malaria control inter-
ventions, the first two criteria are addressed by the
existing scientific studies that document the efficacy of
interventions in controlled trials–that is, the interven-
tions have been proven to reduce morbidity and mortal-
ity and it is fully plausible that their use in national
settings can achieve the comparable results. The country
data on intervention coverage scale-up and impact mea-
s u r e sl a r g e l ya d d r e s sc r i t e r i a3t h r o u g h8 .F o rt h e
strength and specificity of association and the temporal
congruity (criteria 3, 4 and 5), a programme assessment
may lack the most stringent criteria, however in the
examples of Bioko Island, Zambia and Zanzibar, the
association and time link between malaria control scale
up and reductions in malaria morbidity and mortality is
strong; and efforts to examine alternative explanations
did not demonstrate substantial weaknesses with the
associations. The timing of the intervention application
and the benefit achieved is closely sequenced. The
B i o k oI s l a n de x p e r i e n c es h o w sad r a m a t i ca n da l m o s t
immediate drop in child mortality following the applica-
tion of the malaria prevention and treatment package
[41]. Similarly, the experience in Zanzibar showed a dra-
matic response to a combination of IRS, ITNs, and
aggressive diagnosis and treatment [34]. Regarding bio-
logic-gradient or dose-response, the sum of the multi-
country information may not yet fully establish the
dose-response effect where higher coverage is directly
linked to higher impact. However, it is quite clear that
low coverage of malaria interventions remains linked to
limited improvements in child survival.
As for coherence of the evidence, it is critical to
examine alternative explanations. Factors that could
offer alternative explanations for the suggested link
between malaria control scale-up and malaria morbidity
and mortality reductions might include: 1) variations in
rainfall and temperature; 2) broad socio-economic
change; 3) changing HIV conditions; 4) other child
health interventions discussed previously that might
account for the differences; and/or 5) biologic changes
in the malaria-vector-human cycle that is making
malaria infection and illness less virulent. Many of the
studies address and account for rainfall and temperature
Figure 10 Rates of all-cause under-five mortality on Bioko Island, Equatorial Guinea: pre- and post-malaria control interventions (IRS,
ITNs, case management). Source: Data taken directly from Table four in Kleinschmidt et al [41]. Malaria interventions included indoor residual
spraying (IRS) and malaria case management with diagnosis and artemisinin-based combination therapy; increased household ownership of
insecticide-treated mosquito nets (ITNs) was added in 2007.
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explanations of marked reductions in malaria during
this time interval in most African countries. In Ethiopia,
weather patterns are thought to have contributed to a
substantial malaria epidemic from 2003 through 2005,
so some of the findings there may be accounted for by
this earlier period with high malaria as a comparison
time for more recent scale-up and impact; however, this
is not the case for other country settings. Some socio-
economic change certainly occurred in Bioko Island
with the growth of the oil industry, and improved cop-
per prices in the 2005 through 2008 interval may have
contributed indirectly in Zambia–but again, such socio-
economic improvements occur in many countries but
are not likely to explain the dramatic reduction in child-
hood mortality documented in the setting of SUFI. HIV
rates have not dropped consistently across these coun-
tries, but improved treatment with anti-retroviral drugs
may have contributed partially to the improved child
survival and reductions in fever and malaria incidence
and prevalence.
There are numerous challenges in a multi-country
review of programme scale-up and its consequences.
Largely, the study relied on national population-based
survey data, which typically come from DHS, MICS and
MIS, which have been repeatedly compared and updated
to assure common wording and sequence of questions
and standard reporting procedures; thus it is not
expected that these different surveys introduced sub-
stantial bias in comparisons. For some questions, the
timing of the survey is important. For example ITN use
may vary substantially between the high transmission
season and the hotter and dryer seasons when few or no
mosquitoes prompt people to use their ITNs less; this
would generally bias any results to being underestimates
of actual ITN use in the peak transmission season. For
counting malaria cases, however, a substantial variability
is expected between and within countries as the intro-
duction and expansion of diagnostics has increasingly
excluded non-malarial fevers over time; unfortunately
this leads to over-reporting of progress in reducing
malaria cases and it is not possible to fully account for
this in this summary review. In addition, child survival
m a yw e l lh a v eb e e ni m p r o v i n gi ns o m eo ft h e s ec o u n -
tries prior to intervention scale-up. The health systems
must be reasonably robust to deliver the spectrum of
malaria interventions through child health services,
maternal health services, and community outreach and
campaign distributions. These systems likely have been
delivering other services (e.g., immunizations, vitamin A,
and treatment of other illnesses) that improve child sur-
vival. While a clear majority alternative explanation for
the improved health in these countries was not
observed, each of these (and possibly additional factors)
should be considered carefully by programmes examin-
ing the benefit of their malaria control scale-up.
Some of the observed measures of impact are at
higher programme effectiveness levels than were pre-
dicted based on the coverage levels achieved and the
known intervention efficacy data. This should not be
surprising for several reasons. First, programmes are
typically using multiple interventions simultaneously
(ITNs, IRS, IPTp, and case management), not just one
intervention that might have been tested in a controlled
trial. Second, the controlled trials likely improved the
services for both the intervention and comparison
groups, thus making the efficacy estimate a conservative
one. In contrast, programmes are being compared his-
torically to times when much less was being done over-
all for malaria and possibly for other child health
interventions, thus their observed gains appear large.
No single intervention can be credited with these dra-
matic improvements in the many countries; IRS may be
credited in one country, ITNs in another, and effective
drugs for case management in a third country. In fact, it
is more likely that the composite package of preventive
interventions (ITNs, IRS, IPTp) and treatment interven-
tions (changing to highly effective drugs and using qual-
ity diagnostics) is responsible for the level of mortality
r e d u c t i o ni ni n d i v i d u a lc o u n t r i e s .I ns o m es e t t i n g st h e
benefit has been attributed to a specific intervention but
this may be because countries have not clearly
accounted for the role of the other interventions. For
example, in most countries with marked improvement
of case management, it is likely that the use of good
diagnostics is responsible for much of the decline in
reported malaria cases - by leading to the exclusion of
non-malaria fevers from that case count. While scale-up
of case management may have been the weakest of the
efforts to date, recent emphasis on diagnostics may help
further address this in the coming years. Of note, the
overall effect of malaria control has been generated lar-
gely through the reduction of malaria transmission–both
vector control and aggressive diagnosis and treatment in
places like Zanzibar have contributed substantially to
reduced transmission. It is inevitable that programme
orientation to sustain the current gains will require an
intense focus on transmission reduction.
Conclusion
Coincident with the dramatic increase in funding over the
past five years, African governments and their partners
have documented the health impact that malaria control
can produce by a coordinated national scale-up of the
package of malaria control interventions. The important
observation is that the evolving malaria control approach,
SUFI, is robust in terms of predictably producing health
impact and this can be led by national governments with
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programme scale-up has achieved substantial impact
across a growing array of African countries. The reduc-
tions in child mortality are consistent with or even greater
than the estimated 20% reduction in all-cause child mor-
tality predicted from the controlled trials of ITNs. In 2010,
hundreds of thousands of African children will not die of
malaria because of recent national investments. This
represents an impressive health impact across the region
achieved through national-scale implementation of effec-
tive prevention and treatment measures. Malaria control
with the current array of interventions represents a com-
pelling investment that predictably prevents childhood
deaths. But malaria control currently requires daily atten-
tion, the ITN must be hung tomorrow just as it was last
night, and it must be replaced when it loses efficacy. The
global malaria community now understands that malaria
control is indeed the best buy currently in terms of child
survival in Africa; and much still remains to be done in
many countries including countries with large populations
and persistent high malaria burdens. Malaria control can-
not be sustained as an open-ended recurrent cost for
donors and governments. The critical test will be develop-
ing the country experience with programming for incre-
mental elimination of transmission to sustain the benefits
of malaria control for future generations of African
children.
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